InvestorsHub Logo
Followers 8
Posts 119
Boards Moderated 0
Alias Born 11/10/2022

Re: Emannow post# 6207

Thursday, 02/08/2024 4:44:33 PM

Thursday, February 08, 2024 4:44:33 PM

Post# of 7575
I respectfully disagree Emannow. During commercial launch the customer is the injector and with time you eventually migrate to DTC marketing more and more once the brand is established. Revance does not have enough cash to launch a nationwide DTC marketing campaign. It is much more effective to spend $3M giving away $75 coupons = 40,000 patient treatments with many treatments going to first time Daxi patients in new accounts. Revance needs 3 to 5K reordering accounts to get Daxxify into 500K patients asap before word of mouth marketing starts to take hold and injectors get the positive feedback which will allow the hockey stick adoption from 2025 to 2028. I am guessing they are approaching 250K patients right now that have tried Daxxify.

My practice just launched the rebates this past Tuesday and I have already added over 10 first time Daxxify users in 2 1/2 days as a single injector and I have used around 20 rebates. Rebates are being given only to clients who use a minimum number of units so 2 out of 3 Daxxify patients are getting the rebate so far. This is a very fast and atypical adoption rate. I am having very little pushback on them switching from Botox despite their Alle coupons.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News